All Stories

  1. Enantioselective analysis of metoprolol in plasma of hypertensive patients undergoing long-term therapy: Insights for personalized medicine
  2. Paracetamol solubility in methanol + water mixtures at T  = (298.2 to 318.2) K: experimental measurement, thermodynamic analysis, and mathematical modeling
  3. Solubility of nifedipine in twenty-one mono-solvents at various temperatures
  4. Solubility of anti-epileptic drugs in mono-solvents at various temperatures: a data-driven simulation approach
  5. Solubility determination and thermodynamic analysis of amlodipine besylate in non-aqueous mixtures of polyethylene glycol 400 and 1-propanol from 293.2 K to 313.2 K
  6. Development of an optical probe based on zinc nitride quantum dots for methotrexate determination in biological samples
  7. Monitoring of Iranian pharmaceutical studies in the last decade: A scientometric study
  8. Profiling metoprolol enantiomers in urine of hypertensive patients
  9. Some comments on the solubility of rivaroxaban and its numerical analysis methods using various algorithms
  10. Solubility and thermodynamic analysis of amlodipine besylate in mixtures of propylene glycol and 1-propanol from 293.2 to 323.2 K
  11. Improved Solubility Predictions in scCO2 Using Thermodynamics-Informed Machine Learning Models
  12. Improved Solubility Predictions in scCO2 Using Thermodynamics-Informed Machine Learning Models
  13. Pilar Bustamante and Her Advances in Thermodynamic and Solubility Parameters
  14. Application of high-resolution analytical techniques in breathomics studies
  15. Comments on “Artificial intelligence aided pharmaceutical engineering: Development of hybrid machine learning models for prediction of nanomedicine solubility in supercritical solvent”
  16. Solubility of Sildenafil Citrate in Polyethylene Glycol 200 + Water Mixtures at 293.2-313.2 K
  17. Effect of Ethanol on the Solubility and Apparent Specific Volume of Sodium Sulfadiazine in Aqueous Mixtures
  18. Solubility data of deferiprone in propylene glycol and 1-propanol mixtures at 293.2–323.2 K
  19. Improved Solubility Predictions in scCO2 Using Thermodynamics-Informed Machine Learning Models
  20. Solubility of Deferiprone in Non-Aqueous Mixtures of Polyethylene Glycol 400 and 1-Propanol at 293.2–323.2 K
  21. Prediction of Drugs Solubility in Mono-Solvent Systems at Different Temperatures Using a Single Determination
  22. Corrections on “Determination of solubility of sildenafil citrate in propylene glycol + 2-propanol and N-methyl pyrrolidone + water: Comparing solubilization power of aqueous or non-aqueous mixtures”
  23. Testing the prediction capability of trained models: sildenafil citrate solubility in propylene glycol and 1-propanol mixtures at different temperatures
  24. Simulation of azole drugs’ solubility in mono and binary systems at different temperatures
  25. Solubility of sildenafil citrate in acetonitrile + water mixture at different temperatures
  26. Metoprolol Metabolites’ Ratios and/or Enantiomeric Profiles: A Simple and Low-cost Tool for Personalized Medicine through CYP2D6 Phenotyping
  27. Equilibrium Solubility of Sulfadiazine in (Acetonitrile + Ethanol) Mixtures: Determination, Correlation, Dissolution Thermodynamics, and Preferential Solvation
  28. Study of sertraline solubility, solvent effect, and modeling in the aqueous mixtures of dimethyl sulfoxide or diethylene glycol monoethyl ether at several temperatures and its use in the formulation of nanosuspensions
  29. Solubility of glibenclamide in carbitol and 1-propanol mixtures at different temperatures
  30. Electromembrane Extraction of Ofloxacin from Human Plasma and Its Quantification by Capillary Electrophoresis
  31. Solubility of codeine phosphate in ethylene glycol + N -methyl-2-pyrrolidone mixtures at different temperatures
  32. Equilibrium solubility and mathematical modelling of glibenclamide in cosolvent mixtures of glycols and alcohols
  33. Dissolution Thermodynamics and Preferential Solvation of Phenothiazine in Some Aqueous Cosolvent Systems
  34. Solubility prediction of drugs in mono-solvents at various temperatures: Ciprofloxacin data simulation
  35. Determination of solubility of sildenafil citrate in propylene glycol + 2-propanol and N-methyl pyrrolidone + water: Comparing solubilization power of aqueous or non-aqueous mixtures
  36. The effects of ascorbic acid and tartaric acid on pioglitazone hydrochloride solubility
  37. Solubility of atenolol in aqueous propylene glycol mixtures revisited: IKBI preferential solvation analysis
  38. Solubility Measurement and Correlation of Alprazolam in Carbon Dioxide with/without Ethanol at Temperatures from 308 to 338 K and Pressures from 120 to 300 bar
  39. Simulation of Co-Crystal Solubility in the Mono-Solvents at Different Temperatures
  40. Dissolution thermodynamics and solubility prediction of satranidazole in mono-solvent systems at various temperatures using a single determination
  41. Au Nanostars Coated with a Thin Film of MIL-100 (Fe) for SERS-Based Sensing of Volatile Organic Compound Indicators in Saliva
  42. Equilibrium solubility determination, modeling and thermodynamic analysis of isophthalic acid in aqueous co-solvent mixtures of propylene glycol, ethylene glycol and glycerol
  43. Digital Image Colorimetry for Determination of Ethanol in Exhaled Breath Condensate
  44. Carbonized aerogel/ZnO-based dispersive solid phase extraction of daclatasvir and sofosbuvir from biological samples prior to liquid chromatography–tandem mass spectrometry
  45. Development of a nanocomposite hydrogel catalyzed H2O2/TMB system for determination of chlordiazepoxide in exhaled breath condensate
  46. Recent advancements in the specific determination of carcinoembryonic antigens using MOF-based immunosensors
  47. Utilizing a graphene quantum dot/hydrogel nanocomposite for determination of cisplatin in urine samples
  48. Assessing the impact of quaternary ammonium compounds with different stoichiometric ratio on atorvastatin calcium solubility
  49. Prediction of Paracetamol Solubility in Binary Solvents Using Reichardt’s Polarity Parameter Combined Model
  50. Equilibrium Solubility of Acetaminophen in Ternary Mixtures as a Tool for Design of Concentrated Parenteral Medications
  51. Interactions between components of choline chloride/propylene glycol or ethylene glycol deep eutectic solvents in the presence of water by determination of amlodipine besylate solubility profile
  52. Revisiting the Total Hildebrand and Partial Hansen Solubility Parameters of Analgesic Drug Meloxicam
  53. Solubility of codeine phosphate in N -methyl-2-pyrrolidone + 1-propanol mixtures at different temperatures
  54. A global model for simulation of drug solubility in mono-solvents at different temperatures
  55. A new set of solute descriptors to calculate solubility of drugs in mono-solvents
  56. Solubility of glimepiride in mono- and mixed-solvents at various temperatures: Proposing practical strategy for industrial applications
  57. Comparative Drug Solubility Studies Using Shake-Flask Versus a Laser-Based Robotic Method
  58. Dissolution and thermodynamic study of lamotrigine in propylene glycol + 1-propanol mixtures
  59. Biomarkers in Exhaled Breath Condensate as Fingerprints of Asthma, Chronic Obstructive Pulmonary Disease and Asthma–Chronic Obstructive Pulmonary Disease Overlap: A Critical Review
  60. Determination of the solubility profile of isophthalic acid in some aqueous solutions of betaine-based deep eutectic solvents: Study the extent of H-bonding interactions between starting materials of deep eutectic solvents in aqueous medium
  61. Online preconcentration and chiral separation of ofloxacin in exhaled breath condensate by capillary electrophoresis
  62. Integrated Smart Gas Tracking Device with Artificially Tailored Selectivity for Real-Time Monitoring Food Freshness
  63. Integrated Smart Gas Tracking Device with Artificially Tailored Selectivity for Real-Time Monitoring Food Freshness
  64. Integrated Smart Gas Tracking Device with Artificially Tailored Selectivity for Real-Time Monitoring Food Freshness
  65. In-situ preparation of norepinephrine-functionalized silver nanoparticles and application for colorimetric detection of tacrolimus in plasma samples
  66. A Smartphone Digital Image Colorimetric Method Based on Nanoparticles for Determination of Lamotrigine
  67. The Importance of Qualitative/Quantitative Analytical Tools in COVID-19 Vaccine Development
  68. Low fouling aptasensing of rivaroxaban in real samples using poly (toluidine blue) decorated by silver nanoparticle: A new platform for the cardiovascular disease analysis
  69. Dispersive solid‐phase extraction of risperidone from plasma samples using graphene oxide aerogels and determination with liquid chromatography
  70. Thermodynamic analysis of atorvastatin calcium in solvent mixtures at several temperatures
  71. Solubility enhancement of atorvastatin calcium and ethanol-mediated transition with some surfactants
  72. Hyaluronic acid-magnetic fluorescent polydopamine/gold-based fluorescent probe for bioimaging of CD44 over-expressed cancer cells
  73. Utilizing Rayleigh light scattering of anthracene nanoparticles for determination of p-cresol in exhaled breath condensate
  74. Equilibrium solubility investigation and thermodynamic aspects of paracetamol, salicylic acid and 5-aminosalicylic acid in polyethylene glycol dimethyl ether 250 + water mixtures
  75. Solubility and thermodynamics of celecoxib in N-methyl-2-pyrrolidone and (ethanol, 1-propanol) binary solvent mixtures at (293.15 to 313.15) K
  76. Chiral resolution methods for racemic pharmaceuticals based on cocrystal formation
  77. Efficient dispersive solid-phase extraction of methylprednisolone from exhaled breath of COVID-19 patients
  78. The influence of advanced materials on the analytical performance of semiconductor-based gas sensors
  79. Recent advances in gold nanoparticle-based colorimetric aptasensors for chemical and biological analyses
  80. Correlation of Surface Tension of Mono-Solvents at Various Temperatures
  81. Effect of N-Methyl-pyrrolidone (NMP) on the Equilibrium Solubility of Meloxicam in Aqueous Media: Correlation, Dissolution Thermodynamics, and Preferential Solvation
  82. Selection of Specific Aptamer against Rivaroxaban and Utilization for Label-Free Electrochemical Aptasensing Using Gold Nanoparticles: First Announcement and Application for Clinical Sample Analysis
  83. A sensitive determination of morphine in plasma using AuNPs@UiO-66/PVA hydrogel as an advanced optical scaffold
  84. Correlation of inflammatory biomarkers with the diversity of Bacteroidaceae, Bifidobacteriaceae, Prevotellaceae and Lactobacillaceae families in the intestinal microbiota of patients with end stage renal disease
  85. Synthesis and application of concanavalin A-conjugated green luminescent gold nanoparticle/fluorescent polydopamine nanoparticles for specific differentiation of cancer cells from normal cells using glycan bioreceptors
  86. Increasing the Equilibrium Solubility of Meloxicam in Aqueous Media by Using Dimethyl Sulfoxide as a Cosolvent: Correlation, Dissolution Thermodynamics and Preferential Solvation
  87. Caffeine solubility in aqueous solutions of polyethylene glycol dimethyl ether 250: measurement and thermodynamic modeling
  88. Expanding the Equilibrium Solubility and Dissolution Thermodynamics of Benzoic Acid in Aqueous Alcoholic Mixtures
  89. Solubility of paracetamol in binary mixtures of biodegradable betaine/ethylene glycol deep eutectic solvent and water: measurement and correlation
  90. Thermodynamic Analysis for the Solubility of Allopurinol in Aqueous and Non-aqueous Mixtures at Various Temperatures
  91. Aptamer-functionalized metal organic frameworks as an emerging nanoprobe in the food safety field: Promising development opportunities and translational challenges
  92. Exploring the interaction of clonazepam and diazepam with tau protein: Multispectral and molecular docking studies
  93. The effect of cosolvents and surfactants on the solubility of sulfasalazine
  94. Simulation of dielectric constants of solvents at various temperatures using Catalan parameters
  95. Solubility of amlodipine besylate in acetonitrile + water binary mixtures at various temperatures: Determination, modelling, and thermodynamics
  96. Professor Jalil Afshar; the Founding Editor of Pharmaceutical Sciences
  97. Solubility of Bosentan in Polyethylene Glycol 400 + Water Mixtures: Experimental and Mathematical Computations
  98. Determination and correlation of naproxen solubility in polyethylene glycol dimethyl ether 250 and water mixtures
  99. Application of microcrystalline cellulose as an efficient and cheap sorbent for the extraction of metoprolol from plasma and wastewater before HPLC–MS/MS determination
  100. Drug Solubility Correlation Using the Jouyban–Acree Model: Effects of Concentration Units and Error Criteria
  101. Bosentan solubility in binary mixtures of polyethylene glycol dimethyl ether 250 and water at different temperatures
  102. Solubility of tadalafil in aqueous mixtures of Transcutol® and PEG 400 revisited: correlation, thermodynamics and preferential solvation
  103. Exhaled breath condensate efficacy to identify mutations in patients with lung cancer: A pilot study
  104. Equilibrium solubility of 6-methylcoumarin in some (ethanol + water) mixtures: determination, correlation, thermodynamics and preferential solvation
  105. Michael H. Abraham and his developed parameters: Various applications in medicine, chemistry and biology
  106. Thermodynamic study of the aqueous pseudo-binary mixtures of betaine-based deep eutectic solvents at T = (293.15 to 313.15) K
  107. Equilibrium solubility of trans-resveratrol in {acetone (1) + water (2)} mixtures: Correlation, dissolution thermodynamics and preferential solvation
  108. An overview on nanostructure-modified supported liquid membranes for the electromembrane extraction method
  109. Development of a β-cyclodextrin-modified gold nanoparticle-assisted electromembrane extraction method followed by capillary electrophoresis for methadone determination in plasma
  110. UiO-66-based metal–organic framework for dispersive solid-phase extraction of vanillylmandelic acid from urine before analysis by capillary electrophoresis
  111. Sensing Methods of Immunosuppressant Drugs: Calcineurin Inhibitors and Purine Synthesis Inhibitor Agents
  112. Applications of Advanced Materials for Non-Enzymatic Glucose Monitoring: From Invasive to the Wearable Device
  113. Comments on “Solubility and thermodynamic properties of an energetic intermediate in four binary solvents (water + n-butanol, n-pentanol, isobutanol and isoamyl alcohol)”
  114. Solubility, Solvent Effect, and Solvation Performance of MBQ-167 in Aqueous Cosolvent Solutions
  115. A Terbium Metal–Organic Framework Platform for Determination of Lamotrigine in Exhaled Breath Condensate
  116. Correction to “Solubility of 3-Ethyl-5-methyl-(4RS)-2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate Monobenzenesulfonate (Amlodipine Besylate) in Ethanol + Water and Propane-1,2-diol + Water Mixtures a...
  117. Employing Abraham and Hansen Parameters for Solubility Prediction of Ketoconazole in Binary Solvents at Various Temperatures
  118. Crystal engineering of valproic acid and carbamazepine to improve hygroscopicity and dissolution profile
  119. Applications of scaffold-based advanced materials in biomedical sensing
  120. Overview of therapeutic drug monitoring of immunosuppressive drugs: Analytical and clinical practices
  121. Solubility of sildenafil citrate in propylene glycol + ethanol mixtures at different temperatures
  122. Prediction of sulfonamides’ solubilities in the mixed solvents using solvation parameters
  123. Solubility of carvedilol in aqueous mixtures of a deep eutectic solvent at different temperatures
  124. Thermodynamic Modeling and Solubility Study of Satranidazole in Different Monosolvents at Different Temperatures
  125. Additional computations on “Volumetric, acoustic, transport and FTIR studies of binary di-butylamine + isomeric butanol mixtures as potential CO2 absorbents”
  126. Bifonazole dissolved in numerous aqueous alcohol mixtures: Solvent effect, enthalpy–entropy compensation, extended Hildebrand solubility parameter approach and preferential solvation
  127. Development of a deep eutectic solvent-based ultrasound-assisted homogenous liquid-liquid microextraction method for simultaneous extraction of daclatasvir and sofosbuvir from urine samples
  128. Solubility and thermodynamic aspects of etonogestrel in several aqueous co-solvent solutions
  129. A Minireview on Nanoparticle-Based Sensors for the Detection of Coronaviruses
  130. Solubility Measurement, Preferential Solvation, and Solvent Effect of 3,5-Dinitrosalicylic Acid in Several Binary Aqueous Blends
  131. Comments on “Increase in the circulating levels of malondialdehyde in patients with obstructive sleep apnea: a systematic review and meta-analysis”
  132. Solubility measurement and thermodynamic modeling of caffeine in N-methyl-2-pyrrolidone + isopropanol mixtures at different temperatures
  133. Prediction of hypothetical solubility of drugs in phase separated miscible binary solvent mixtures using an interpolation technique
  134. Solubility study of mesalazine in the aqueous mixtures of a deep-eutectic solvent at different temperatures
  135. Solubility, correlation, dissolution thermodynamics and preferential solvation of meloxicam in aqueous mixtures of 2-propanol
  136. Some comments concerning “Measurement and correlation of solubility data for atorvastatin calcium in pure and binary solvent systems from 293.15 K to 328.15 K”
  137. pH-induced Homogeneous liquid–liquid Microextraction Method based on new Switchable Deep Eutectic Solvent for the Extraction of Three Antiepileptic Drugs from Breast Milk
  138. Sensing and bioimaging of lead ions in intracellular cancer cells and biomedical media using amine-functionalized silicon quantum dots fluorescent probe
  139. Solubilization Methods for Paclitaxel and Docetaxel: An Overview
  140. Solubility of trans-resveratrol in {ethanol (1) + water (2)} mixtures revisited: Correlation, dissolution thermodynamics and preferential solvation
  141. Derivatization of γ-Amino Butyric Acid Analogues for Their Determination in the Biological Samples and Pharmaceutical Preparations: A Comprehensive Review
  142. Solubility, Dissolution Thermodynamics and Preferential Solvation of Meloxicam in (Methanol + Water) Mixtures
  143. Extended Hildebrand solubility approach applied to sulphadiazine in aqueous binary mixtures of Carbitol® and N-methyl-2-pyrrolidone at 313.15 K
  144. Solubility of 3-aminosalicylic acid in 2-propanol + water mixtures at different temperatures
  145. o-Nitroacetanilide Equilibrium Solubility in 15 Monosolvents: Experimental Determination, Mathematical Correlation, and Solvent Effect Examination
  146. Solubility, Three-Dimensional Hansen Solubility Parameters, and Solution Thermodynamics of 3,3′-Diaminodiphenyl Sulfone in 14 Neat Solvents from 283.15 to 328.15 K
  147. Concentration profile of tobramycin in exhaled breath condensate after inhalation of a single dose: A pilot study
  148. Recent advances in the determination of unbound concentration and plasma protein binding of drugs: Analytical methods
  149. ImmunoAnalysis: A New Journal to Publish Peer-Reviewed Manuscripts in the Fields of Pharmaceutical Analysis and Immunology
  150. Efficacy of Analytical Technologies in Metabolomics Studies of the Gastrointestinal Cancers
  151. Ultrasound-Assisted Dispersive Liquid-Liquid Microextraction and Capillary Electrophoretic Determination of Tramadol in Human Plasma
  152. Breathomics: Review of Sample Collection and Analysis, Data Modeling and Clinical Applications
  153. Copper nanocluster-based sensor for determination of vancomycin in exhaled breath condensate: A synchronous fluorescence spectroscopy
  154. Validation of a colorimetric method for determination of paracetamol in exhaled breath condensate
  155. Solubility of sulphadiazine in some {Carbitol® (1) + water (2)} mixtures: determination, correlation, and preferential solvation
  156. Ultrasensitive fluorescence detection of antitumor drug methotrexate based on a terbium-doped silica dendritic probe
  157. Using constant-wavelength synchronous fluorescence spectroscopy in nanoparticle-based sensors: a minireview
  158. Waste of Mechanical Ventilators as a Biological Sample for Follow up of Biomarkers and Drugs
  159. Antimicrobial, cytotoxicity, molecular modeling and DNA cleavage/binding studies of zinc-naproxen complex: switching DNA binding mode of naproxen by coordination to zinc ion
  160. Existing Antiviral Options Against SARS-CoV-2 Replication in COVID-19 Patients
  161. A Rapid Strategy for Repurposing Drugs for COVID-19
  162. Solubility of paracetamol in the ternary solvent mixtures of water + ethanol + glycerol at 298.2 and 303.2 K
  163. An overview on terbium sensitized based-optical sensors/nanosensors for determination of pharmaceuticals
  164. Solubilisation of dexamethasone: experimental data, co-solvency and Polarised Continuum Modelling
  165. Microextraction and Chromatographic Analysis of Budesonide Epimers in Exhaled Breath Condensate
  166. Development of Salt Induced Liquid–Liquid Extraction Combined with Amine Based Deep Eutectic Solvent-Dispersive Liquid–Liquid Microextraction; An Efficient Analytical Method for Determination of Three Anti-Seizures in Urine Samples
  167. Solubility of mesalazine in {acetonitrile + water} mixtures at various temperatures
  168. Dissolution thermodynamics and preferential solvation of meloxicam in (acetonitrile + water) mixtures
  169. Trace Extraction of Metoprolol from Plasma, Urine and EBC Samples Using Modified Magnetic Nanoparticles Followed by Spectrofluorimetric Determination for Drug Monitoring Purposes
  170. Electromembrane extraction as a new approach for determination of free concentration of phenytoin in plasma using capillary electrophoresis
  171. In situ Surfactant-based Solid Phase Microextraction of p-cresol in Human Plasma Prior to HPLC Analysis
  172. Investigation of biological activity of nickel (II) complex with naproxen and 1,10-phenanthroline ligands
  173. Determination of Morphine and Its Metabolites in the Biological Samples: An Updated Review
  174. Macromolecular Biomarkers of Chronic Obstructive Pulmonary Disease in Exhaled Breath Condensate
  175. Preferential solvation of some corticosteroids in {ethanol (1) + water (2)} mixtures at 298.2 K
  176. Dissolution thermodynamics and preferential solvation of gliclazide in (Transcutol® + water) mixtures
  177. An Overview on Analytical Methods for Quantitative Determination of Aristolochic Acids
  178. A Comprehensive Review on Developed Pharmaceutical Analysis Methods by Iranian Analysts in 2018
  179. Exhaled Breath Condensate: A Non-Invasive Source for Tracking of Genetic and Epigenetic Alterations in Lung Diseases
  180. An optical sensing platform based on hexacyanoferrate intercalated layered double hydroxide nanozyme for determination of chromium in water
  181. A Simple Colorimetric Method for Determination of Ethanol in Exhaled Breath Condensate
  182. Solubility of codeine phosphate in carbitol + 2-propanol mixture at different temperatures
  183. Exhaled Breath Condensate as a Potential Specimen for Diagnosing COVID-19
  184. Further numerical analyses on the solubility of diazepam in aqueous tert-butanol mixtures
  185. Development of Sodium Sulfate Induced Water Based Dispersive Liquid–Liquid Microextraction for the Extraction of Four Tricyclic Antidepressants in Urine Samples Prior to Their Determination by Gas Chromatography–Mass Spectrometry
  186. Protective Effects of Selenium in Patients with Beta-Thalassemia Major
  187. Predicting the solubility, thermodynamic properties and preferential solvation of sulphamethazine in {acetonitrile + water} mixtures using a minimum number of experimental data points
  188. Increasing DNA binding affinity of doxorubicin by loading on Fe3O4 nanoparticles: A multi-spectroscopic study
  189. Preferential solvation of 4-(4-ethoxyphenyl)-5-(3,4,5-trimethoxybenzoyl)-3,4-dihydropyrimidin-2(1H)-one in {PEG 400 (1) + water (2)} mixtures
  190. A colorimetric nanoprobe based on dynamic aggregation of SDS-capped silver nanoparticles for tobramycin determination in exhaled breath condensate
  191. Determination of phenytoin in exhaled breath condensate using electromembrane extraction followed by capillary electrophoresis
  192. Determination of benzo(a)pyrene in the exhaled breath condensate of cigarette smokers by microextraction and HPLC-UV
  193. Measurement and modelling of the solubility for ketoconazole in {acetonitrile + water} mixtures at T = (293.2 to 313.2) K
  194. Comments on "What if Cocrystallization Fails for Neutral Molecules? Screening Offered Eutectics as Alternate Pharmaceutical Materials: Leflunomide-A Case Study"
  195. Simultaneous Determination of Phenobarbital, Phenytoin, Carbamazepine and Carbamazepine-10,11-epoxide in Plasma of Epileptic Patients
  196. Analytical Techniques for the Determination of Verapamil in Biological Samples and Dosage Forms: An Overview
  197. Equilibrium solubility and apparent specific volume at saturation of sodium sulfadiazine in some aqueous cosolvent mixtures at 298.2 K
  198. Trained models for solubility prediction of drugs in acetonitrile + water mixtures at various temperatures
  199. Mesalazine solubility in the binary mixtures of ethanol and water at various temperatures
  200. exhaled breath condensate
  201. Solubility of sulfacetamide in (ethanol + water) mixtures: Measurement, correlation, thermodynamics, preferential solvation and volumetric contribution at saturation
  202. Comparison of the Models for Correlation of Drug Solubility in Ethanol + Water Binary Mixtures
  203. Solubility of lamotrigine in acetonitrile + water mixtures at various temperatures
  204. Further Analysis on Solubility Measurement and Thermodynamic Modeling of Benzoic Acid in Monosolvents and Binary Mixtures
  205. Volumetric and acoustic properties of ionic liquid, 1-hexyl-3-methylimidazolium bromide in 1-hexanol, 1-heptanol and 1-octanol at T = (298.15–328.15) K
  206. Solubility of celecoxib in carbitol + water mixtures at various temperatures: experimental data and mathematical modelling
  207. Solubility of acetaminophen in 1-propanol + water mixtures at T = 293.2–313.2 K
  208. Highly sensitive and specific cytosensing of HT 29 colorectal cancer cells using folic acid functionalized-KCC-1 nanoparticles
  209. Experimental Solubility and Density Functional Theory Studies of Deferasirox in Binary Solvent Mixtures: Performance of Polarizable Continuum Model and Jouyban–Acree Model
  210. Equilibrium solubility and apparent specific volume at saturation of sodium diclofenac in {formamide (1)/N-methylformamide (1)/or N,N,-dimethylformamide (1) + water (2)} mixtures at 298.2 K
  211. Comprehensive models for density prediction of ionic liquid + molecular solvent mixtures at different temperatures
  212. Lamotrigine solubility in 1-propanol + water mixtures at different temperatures: experimental data and mathematical modelling
  213. Further computations on the solubility of 2-methyl-1,3-benzothiazol-5-amine in ethanol + water mixtures at several temperatures
  214. Density, Speed of Sound, and Viscosity of Diethylene Glycol Monoethyl Ether + N,N-Dimethylformamide (Ethanol, Water) at T = 288.15–318.15 K
  215. Solubility of sulphadiazine in (acetonitrile + water) mixtures: measurement, correlation, thermodynamics and preferential solvation
  216. Direct Monitoring of Verapamil Level in Exhaled Breath Condensate Samples
  217. Determination of valproic acid and 3-heptanone in plasma using air-assisted liquid-liquid microextraction with the assistance of vortex: Application in the real samples
  218. A new hypothesis to investigate bioequivalence of pharmaceutical inhalation products
  219. A microscale spectrophotometric method for quantification of doxorubicin in exhaled breath condensate
  220. Colorimetric determination of phenytoin using indoxyl sulfate capped silver nanoparticles
  221. Determination of proline in human plasma samples using the encapsulation of proline dehydrogenase enzyme in dendritic silica: a new platform for the enzymatic biosensing of amino acids
  222. Development of a Micellar Electrokinetic Chromatographic Method with Indirect UV Detection for Pregabalin Determination in Serum Samples
  223. Solubility of celecoxib in 1-propanol + water mixtures at T= (293.2–313.2) K: experimental data and thermodynamic analysis
  224. Study of some volumetric properties of {ethanol (1) + propylene glycol (2) + water (3)} mixtures at several temperatures
  225. Smart systems for determination of drug’s solubility
  226. Solubility of minoxidil in binary mixture of ethanol + water at various temperatures
  227. Solubilization of drugs using sodium lauryl sulfate: Experimental data and modeling
  228. A Sensitive Determination of Ammonia and Nitrite in Exhaled Breath Condensate of Healthy Humans by Using Berthelot Reaction
  229. Measurement and modelling of solubility data for bosentan in 1-propanol + water mixtures at various temperatures
  230. Equilibrium solubility and apparent specific volume of lidocaine.HCl.H2O in some {cosolvent (1) + water (2)} mixtures at 298.2 K
  231. The solubility of bosentan in aqueous-2-propanol mixtures at several temperatures, measurement and data correlation
  232. Determination of verapamil in exhaled breath condensate by using microextraction and liquid chromatography
  233. Experimental determination and correlation of bosentan solubility in (PEG 200 + water) mixtures at T= (293.15–313.15) K
  234. Solubility and thermodynamics of lamotrigine in carbitol + water mixtures from T = (293.2 to 313.2) K
  235. Simultaneous determination of valproic acid and its main metabolite in human plasma using a small scale dispersive liquid–liquid microextraction followed by gas chromatography–flame ionization detection
  236. Avoid using spectrophotometric determination of malondialdehyde as a biomarker of oxidative stress
  237. Solution thermodynamics and preferential solvation of hesperidin in aqueous cosolvent mixtures of ethanol, isopropanol, propylene glycol, and n-propanol
  238. Comment on “Measurement and Correlation of the Solubility of 2,6-Dihydroxybenzoic Acid in Alcohols and Binary Solvents”
  239. Solubility of bosentan in {propylene glycol + water} mixtures at various temperatures: experimental data and mathematical modelling
  240. Equilibrium solubility, preferential solvation and apparent specific volume of sucrose in some {cosolvent (1) + water (2)} mixtures at 298.2 K
  241. Pre-concentration and quantification of aluminum in fish samples using a dispersive liquid–liquid micro-extraction–spectrofluorimetric method based on Al(III)–8-hydroxyquinoline complex’s fluorescence properties
  242. Solubility of Etoricoxib in Aqueous Solutions of Glycerin, Methanol, Polyethylene Glycols 200, 400, 600, and Propylene Glycol at 298.2 K
  243. Solubilization of naproxen using N-methyl-2-pyrrolidone or ethanol and β-cyclodextrin
  244. Solution thermodynamics and preferential solvation of triclocarban in {1,4-dioxane (1) + water (2)} mixtures at 298.15 K
  245. Exhaled breath condensate as an alternative sample for drug monitoring
  246. Determination and mathematical modelling of budesonide solubility in N-methyl-2-pyrrolidone + water mixtures from T = 293.2 to 313.2 K
  247. Further calculations on solubility of dipyrone in some binary solvent mixtures at various temperatures
  248. Essential Oil Constituents of Phlomis pungens Willd. from Azerbaijan
  249. Solubility of budesonide in {ethanol + water} mixtures from T = (293.2 to 313.2) K: Experimental measurement and mathematical modelling
  250. Preferential solvation of some antiepileptic drugs in {cosolvent (1) + water (2)} mixtures at 298.15 K
  251. Deferiprone solubility in some non-aqueous mono-solvents at different temperatures: experimental data and thermodynamic modelling
  252. Solubility of sildenafil citrate in propylene glycol + water mixtures at various temperatures
  253. Prediction of Electrophoretic Mobility of Analytes Using Abraham Solvation Parameters by Different Chemometric Methods
  254. Study of some volumetric and refractive properties of {PEG 300 (1) + ethanol (2)} mixtures at several temperatures
  255. Solubility and preferential solvation of benzocaine in {methanol (1) + water (2)} mixtures at 298.15 K
  256. Comment on “Measurement and Correlation of the Solubility of Maltitol in Different Pure Solvents, Methanol–Water Mixtures, and Ethanol–Water Mixtures”
  257. Volumetric properties of {PEG 200 (or 300) (1) + water (2)} mixtures at several temperatures and correlation with the Jouyban–Acree model
  258. Correct Derivation of Cosolvency Models and Some Comments on “Solubility of Fenofibrate in Different Binary Solvents: Experimental Data and Results of Thermodynamic Modeling”
  259. Comment on “Solubility of Trimethoprim in Selected Pure Solvents and (Water + Ethanol/2-Propanol) Mixed-Solvent Systems”
  260. Density, viscosity, surface tension, and molar volume of propylene glycol + water mixtures from 293 to 323 K and correlations by the Jouyban–Acree model
  261. Analysis of deferiprone in exhaled breath condensate using silver nanoparticle-enhanced terbium fluorescence
  262. Chiral separation of methadone in exhaled breath condensate using capillary electrophoresis
  263. Development and validation of a novel fluorometric sensor for hydrogen peroxide monitoring in exhaled breath condensate
  264. A possible reason for the low reproducibility of malondialdehyde determinations in biological samples
  265. Reliability of Malondialdehyde Measurements as a Marker of Oxidative Stress in Pediatrics
  266. Solubility and preferential solvation of phenacetin in methanol + water mixtures at 298.15 K
  267. Analysis of methadone in EBC
  268. Forced degradation studies of biopharmaceuticals: Selection of stress conditions
  269. Prediction of deferiprone solubility in some non-aqueous binary solvent mixtures at various temperatures
  270. An Automated System for Determining Drug Solubility Based on Laser Monitoring Technique
  271. Capillary electrophoresis with UV detection, on-line stacking and off-line dispersive liquid–liquid microextraction for determination of verapamil enantiomers in plasma
  272. Prediction of analytes' electrophoretic mobility in mixed solvent buffers using Abraham solvation parameters
  273. Solubility of Tadalafil in Pharmaceutical Solvent Mixtures at 298.2K
  274. Solubility of Ketoconazole in Ethanol + Water Mixtures at Various Temperatures
  275. Prediction of deferiprone solubility in aqueous mixtures of ethylene glycol, propylene glycol and polyethylene glycol 400 at various temperatures
  276. Solubility and preferential solvation of meloxicam in methanol+water mixtures at 298.15K
  277. Viscosity and surface tension of glycerol + N-methyl-2-pyrrolidone mixtures from 293 to 323 K
  278. Solubility of Sodium Acetate in Ternary Mixtures of Methanol, 1-Propanol, Acetonitrile, and Water at 298.2 K
  279. Physicochemical characterization of a new cocrystal of ketoconazole
  280. Discrimination of saffron based on thin-layer chromatography and image analysis
  281. A Simple Stability Indicating CZE Method for the Analysis of Octreotide Acetate
  282. Composition and Temperature Dependence of Density, Surface Tension, and Viscosity of EMIM DEP/MMIM DMP + Water + 1-Propanol/2-Propanol Ternary Mixtures and Their Mathematical Representation Using the Jouyban–Acree Model
  283. Mesoporous (organo) silica decorated with magnetic nanoparticles as a reusable nanoadsorbent for arsenic removal from water samples
  284. Solubility prediction of pharmaceuticals in dioxane+water mixtures at various temperatures: Effects of different descriptors and feature selection methods
  285. SOLUBILITY OF ACETAMINOPHEN AND IBUPROFEN IN BINARY AND TERNARY MIXTURES OF POLYETHYLENE GLYCOLS 200 AND 400, PROPYLENE GLYCOL, AND WATER AT 25°C
  286. Solubility Determination of Tris(hydroxymethyl)aminomethane in Water + Methanol Mixtures at Various Temperatures Using a Laser Monitoring Technique
  287. Biological Sample Preparation: Attempts on Productivity Increasing in Bioanalysis
  288. Quantitative structure activity relationship and docking studies of imidazole-based derivatives as P-glycoprotein inhibitors
  289. Preferential solvation of methocarbamol in aqueous binary co-solvent mixtures at 298.15 K
  290. Desirability function approach for the optimization of an in-syringe ultrasound-assisted emulsification-microextraction method for the simultaneous determination of amlodipine and nifedipine in plasma samples
  291. Electropolymerization of taurine on gold surface and its sensory application for determination of captopril in undiluted human serum
  292. Interaction of human serum albumin with Fe(III)–deferasirox studied by multispectroscopic methods
  293. Solubility of Ketoconazole in Polyethylene Glycol 200 + Water Mixtures at 298.2–318.2 K
  294. Determination of lisinopril using β-cyclodextrin/graphene oxide-SO3H modified glassy carbon electrode
  295. Solubility of fluphenazine decanoate in aqueous mixtures of polyethylene glycols 400 and 600 at various temperatures
  296. Capillary Electrophoresis with Organic Solvents in Pharmaceutical Analysis: A Systematic Guide through the Background
  297. Solubility of carbamazepine, nicotinamide and carbamazepine–nicotinamide cocrystal in ethanol–water mixtures
  298. Studies of interaction between terbium(III)-deferasirox and double helix DNA by spectral and electrochemical methods
  299. Salt-Assisted Lle Combined with Field-Amplified Sample Stacking in Ce for Improved Determination of Beta Blocker Drugs in Human Urine
  300. Magnetic nanoparticles incorporated on functionalized mesoporous silica: an advanced electrochemical sensor for simultaneous determination of amiodarone and atenolol
  301. A new mechanistic approach to elucidate furosemide electrooxidation on magnetic nanoparticles loaded on graphene oxide modified glassy carbon electrode
  302. Solubility of clonazepam and diazepam in binary and ternary mixtures of polyethylene glycols 400 or 600, propylene glycol and water at 298.2K - experimental data and modeling
  303. Solubility of methocarbamol in some cosolvent+water mixtures at 298.15K and correlation with the Jouyban–Acree model
  304. Solubility of Carvedilol in Ethanol + Propylene Glycol Mixtures at Various Temperatures
  305. Solubility of Sodium Acetate in Binary Mixtures of Methanol, 1-Propanol, Acetonitrile, and Water at 298.2 K
  306. Solubility Data of Diazepam in Binary and Ternary Mixtures of PEGs 200 and 400 with N-Methyl Pyrrolidone and Water at 298.2 K: Experimental Data and Modeling
  307. SOLUBILITY OF LAMOTRIGINE IN BINARY AND TERNARY MIXTURES OF PEGS 200, 400, AND 600 WITH ETHANOL, PG, AND WATER AT 298.2 K
  308. Solubility and dissolution rate of a carbamazepine–cinnamic acid cocrystal
  309. Ultratrace determination of arsenic in water samples by electrothermal atomic absorption spectrometry after pre-concentration with Mg–Al–Fe ternary layered double hydroxide nano-sorbent
  310. Drug–Drug Coamorphous Systems: Characterization and Physicochemical Properties of Coamorphous Atorvastatin with Carvedilol and Glibenclamide
  311. Comments on “Prediction of Drug Solubility in Lipid Mixtures from the Individual Ingredients”
  312. Serum selenium levels of the very low birth weight premature newborn infants with bronchopulmonary dysplasia
  313. Solubility of amiodarone HCl in propylene glycol+ethanol, propylene glycol+water and their ternary solvent mixtures at 25 and 37°C
  314. Solubility of Nifedipine in Ethanol + Water and Propylene Glycol + Water Mixtures at 293.2 to 313.2 K
  315. Modelling aldehyde oxidase activity in aqueous-organic solvent mixtures at various temperatures
  316. Solubility of ranitidine hydrochloride in solvent mixtures of PEG 200, PEG 400, ethanol and propylene glycol at 25°C
  317. Mathematical Representation of Viscosity of Ionic Liquid + Molecular Solvent Mixtures at Various Temperatures Using the Jouyban–Acree Model
  318. Solubility of lamotrigine in binary and ternary mixtures of N-methyl pyrrolidone and water with polyethylene glycols 200, 400, and 600 at 298.2K
  319. Nickel-aluminum layered double hydroxide as a nano-sorbent for the solid phase extraction of selenium, and its determination by continuous flow HG-AAS
  320. Determination of heparin using terbium-danofloxacin as a luminescent probe
  321. Solubility of sulfapyridine in propylene glycol+water mixtures and correlation with the Jouyban–Acree model
  322. Quantitative Structure-activity Relationships of Imidazole-containing Farnesyltransferase Inhibitors Using Different Chemometric Methods
  323. A verapamil electrochemical sensor based on magnetic mobile crystalline material-41 grafted by sulfonic acid
  324. Application of Abraham solvation parameters for surface tension prediction of mono-solvents and solvent mixtures at various temperatures
  325. Dispersive Liquid–Liquid Microextraction Based on Solidification of Floating Organic Droplet Followed by Spectrofluorimetry for Determination of Carvedilol in Human Plasma
  326. Solution Thermodynamics of Piroxicam in some Ethanol + Water Mixtures and Correlation with the Jouyban–Acree Model
  327. Solubility of Clonazepam and Diazepam in Polyethylene Glycol 200, Propylene Glycol, N-Methyl Pyrrolidone, Ethanol, and Water at (298.2 to 318.2) K and in Binary and Ternary Mixtures of Polyethylene Glycol 200, Propylene Glycol, and Water at 298.2 K
  328. Aldehyde Oxidase Activity and Stability in Water-Miscible Organic Solvents
  329. QSBR Study of Bitter Taste of Peptides: Application of GA-PLS in Combination with MLR, SVM, and ANN Approaches
  330. Solubility of 2-Hydroxybenzoic Acid in Water, 1-Propanol, 2-Propanol, and 2-Propanone at (298.2 to 338.2) K and Their Aqueous Binary Mixtures at 298.2 K
  331. Solubility of 3-Ethyl-5-methyl-(4RS)-2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate Monobenzenesulfonate (Amlodipine Besylate) in Ethanol + Water and Propane-1,2-diol + Water Mixtures at Various Tempe...
  332. Volumetric Properties of Glycerol Formal + Propylene Glycol Mixtures at Several Temperatures and Correlation with the Jouyban–Acree Model
  333. Solubility of salbutamol and salbutamol sulphate in ethanol+water mixtures at 25°C
  334. Thermodynamic studies of fluphenazine decanoate solubility in PEG 200+water mixtures
  335. A principal component analysis approach for developing retention models in liquid chromatography
  336. Preparation and characterization of ceramic/carbon coated Fe3O4 magnetic nanoparticle nanocomposite as a solid-phase microextraction adsorbent
  337. Effects of captopril on the cysteamine-induced duodenal ulcer in the rat
  338. Volumetric properties of the glycerol formal + water cosolvent system and correlation with the Jouyban–Acree model
  339. HPLC DETERMINATION OF AMLODIPINE IN BIOLOGICAL FLIUIDS USING HOLLOW FIBER BASED LIQUID-LIQUID-LIQUID MICROEXTRACTION
  340. Solubility of 2-Butyl-3-benzofuranyl 4-(2-(Diethylamino)ethoxy)-3,5-diiodophenyl Ketone Hydrochloride (Amiodarone HCl) in Ethanol + Water and N-Methyl-2-pyrrolidone + Water Mixtures at Various Temperatures
  341. Solubility of naproxen in ethyl acetate+ethanol mixtures at several temperatures and correlation with the Jouyban–Acree model
  342. Comment on “Measurement and Correlation of Solubilities of (Z)-2-(2-Aminothiazol-4-yl)-2-methoxyiminoacetic Acid in Different Pure Solvents and Binary Mixtures of Water + (Ethanol, Methanol, or Glycol)”
  343. Density, viscosity, and surface tension of water+ethanol mixtures from 293 to 323K
  344. Spectrofluorimetric Determination of Human Serum Albumin Using Terbium-Danofloxacin Probe
  345. A Validated Micellar Lc Method For Simultaneous Determination of Furosemide, Metoprolol And Verapamil in Human Plasma
  346. Determination of Selenium in Serum Samples of Preterm Newborn Infants with Bronchopulmonary Dysplasia Using a Validated Hydride Generation System
  347. Electrochemical behavior of atenolol, carvedilol and propranolol on copper-oxide nanoparticles
  348. Solubility of Acetaminophen and Ibuprofen in Polyethylene Glycol 600, N-Methyl Pyrrolidone and Water Mixtures
  349. Solubility Prediction of Drugs in Mixed Solvents Using Partial Solubility Parameters
  350. Thermodynamic studies of fluphenazine decanoate solubility in propylene glycol+water mixtures and correlation with the Jouyban–Acree model
  351. Modeling the effects of type and concentration of organic modifiers, column type and chemical structure of analytes on the retention in reversed phase liquid chromatography using a single model
  352. Determination of deferiprone in urine and serum using a terbium‐sensitized luminescence method
  353. Prediction of viscosity of binary solvent mixtures at various temperatures
  354. Mathematical Representation of Fluorescence Intensity of Probes in Aqueous Binary Solvent Mixtures
  355. Terbium‐sensitized fluorescence method for the determination of deferasirox in biological fluids and tablet formulation
  356. Determination and comparison of the total polyphenol contents of fresh and commercial fruit juices
  357. Solubility of Phenothiazine in Water, Ethanol, and Propylene Glycol at (298.2 to 338.2) K and Their Binary and Ternary Mixtures at 298.2 K
  358. Spectrofluorimetric determination of buparvaquone in biological fluids, food samples and a pharmaceutical formulation by using terbium–deferasirox probe
  359. Solubility of Anthracene and Phenanthrene in Ethanol + 2,2,4-Trimethylpentane Mixtures at Different Temperatures
  360. Novel cationic surfactant ion pair based solid phase microextraction fiber for nano-level analysis of BTEX
  361. Solubility of salicylic acid in ethanol, propylene glycol, and N-methyl-2-pyrrolidone at various temperatures and their binary mixtures at 298.2K
  362. Spectrofluorimetric determination of folic acid in tablets and urine samples using 1,10‐phenanthroline‐terbium probe
  363. Spectroscopic Studies on the Interaction of Quercetin–Terbium(III) Complex with Calf Thymus DNA
  364. QSAR and pharmacophore studies of telomerase inhibitors
  365. Prediction of Blood–Brain Distribution: Effect of Ionization
  366. QSPR Modeling using Catalan Solvent and Solute Parameters
  367. Scientometric analysis of the major Iranian medical universities
  368. The Importance of Dielectric Constant for Drug Solubility Prediction in Binary Solvent Mixtures: Electrolytes and Zwitterions in Water + Ethanol
  369. Solubility of Pioglitazone Hydrochloride in Binary and Ternary Mixtures of Water, Propylene Glycol, and Polyethylene Glycols 200, 400, and 600 at 298.2 K
  370. Solubility of Anthracene in C 1 −C 3 Alcohols from (298.2 to 333.2) K and Their Mixtures with 2-Propanone at 298.2 K
  371. Solubility of Acetaminophen and Ibuprofen in the Mixtures of Polyethylene Glycol 200 or 400 with Ethanol and Water and the Density of Solute-Free Mixed Solvents at 298.2 K
  372. Effects of vitamin C and melatonin on cysteamine-induced duodenal ulcer in a cholestatic rat model: A controlled experimental study
  373. Solubility of acetaminophen and ibuprofen in polyethylene glycol 600, propylene glycol and water mixtures at 25°C
  374. Solubility of Anthracene in Binary and Ternary Mixtures of Cyclohexanone, Ethyl Acetate, and Methanol at 298.2 K
  375. QSAR analysis of diaryl COX-2 inhibitors: Comparison of feature selection and train-test data selection methods
  376. Prediction of Dielectric Constants of Binary Solvents at Various Temperatures
  377. Solubility prediction of polycyclic aromatic hydrocarbons in non-aqueous solvent mixtures
  378. Solubility of Phenanthrene in Ternary Mixtures of C1−C4 Alcohols at 298.2 K
  379. Solubility of Benzodiazepines in Polyethylene Glycol 200 + Water Mixtures at 303.2 K
  380. Solubility of 7-Chloro-2-methylamino-5-phenyl-3 H -1,4-benzodiazepine-4-oxide, 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2 H -1,4-benzodiazepin-2-one, and 7-Chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one in (Propane-1,2-diol + Wa...
  381. Modeling the retention behavior of analytes in RPLC with mixed solvent mobile phases using Jouyban-Acree and Abraham models
  382. Solubility of Acetaminophen and Ibuprofen in Binary and Ternary Mixtures of Polyethylene Glycol 600, Ethanol and Water
  383. Solubility of Pioglitazone Hydrochloride in Binary Mixtures of Polyethylene Glycol 400 with Ethanol, Propylene Glycol, N-Methyl-2-pyrrolidone, and Water at 25 .DEG.C
  384. Solubility of Lamotrigine and Diazepam in Propylene Glycol + Water + Carboxymethyl Cellulose at a Temperature of 298.2 K
  385. Solubility of Phenanthrene in Binary Mixtures of C1−C4 Alcohols at 298.2 K
  386. Mathematical representation of xanthine oxidase activity in hydro-organic mixtures
  387. Modeling the effects of different mobile phase compositions and temperatures on the retention of various analytes in HPLC
  388. Total phenols and vitamin C contents of Iranian fruits
  389. Solubility of 5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one, 7-Chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one, and 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine in the Mixtures of Poly(ethylene glycol) 600, Ethanol, and...
  390. Solubility of Pioglitazone Hydrochloride in Aqueous Solutions of Ethanol, Propylene Glycol, and N-Methyl-2-Pyrrolidone at 298.2°K
  391. Solubility of Clonazepam, Diazepam, Lamotrigine, and Phenobarbital in N -Methyl-2-pyrrolidone + Water Mixtures at 298.2 K
  392. Effect of memantine on plasma concentrations of carbamazepine and phenytoin in rats: A controlled experimental study
  393. Solubility of Budesonide, Hydrocortisone, and Prednisolone in Ethanol + Water Mixtures at 298.2 K
  394. Effects of Different Concentrations of Poly(vinyl pyrrolidone) on the Solubility of Lamotrigine and Diazepam in Ethanol + Water Mixtures at 298.2 K
  395. Solubility of Chlordiazepoxide, Diazepam, and Lorazepam in Ethanol + Water Mixtures at 303.2 K
  396. Headspace Solid-Phase Microextraction-Gas Chromatography Method for the Determination of Valproic Acid in Human Serum, and Formulations Using Hollow-Fiber Coated Wire
  397. Prediction of drug solubility in mixed solvents using computed Abraham parameters
  398. Solubility of Phenanthrene in Binary Mixtures of C1−C4 Alcohols + 2-Propanol and Ethanol + Methanol at 298.2 K
  399. Solubility of Lamotrigine, Diazepam, and Clonazepam in Ethanol + Water Mixtures at 298.15 K
  400. Solubility of Lamotrigine, Diazepam, Clonazepam, and Phenobarbital in Propylene Glycol + Water Mixtures at 298.15 K
  401. Comments on “Solubility of Ethyl Maltol in Aqueous Ethanol Mixtures” (Liu, B.-S.; Liu, R.-J.; Hu, Y.-Q.; Hu, Q.-F. J. Chem. Eng. Data 2008, 53, 2712−2714)
  402. Catalytic activity and stability of xanthine oxidase in aqueous-organic mixtures
  403. Incense as a potential drug-delivery method
  404. Solubility of Anthracene in Quaternary Solvent Mixtures of 2,2,4-Trimethylpentane + 2-Propanone + Methanol + Alcohols at 298.15 K
  405. Comments concerning “Study of solute–solvent and solvent–solvent interactions in pure and mixed binary solvents”
  406. Impurity analysis of pharmaceuticals using capillary electromigration methods
  407. Comments on “Thermophysical Properties of para-Anisaldehyde (1) + Chlorobenzene (2) at Temperatures of (303.15, 313.15, and 323.15) K and a Pressure of 0.1 MPa” (Baskaran, R.; Kubendran, T. R. J. Chem. Eng. Data 2008, 53, 97...
  408. Determination of total phenols in tea infusions, tomato and apple juice by terbium sensitized fluorescence method as an alternative approach to the Folin–Ciocalteu spectrophotometric method
  409. Solubility of Anthracene in Ternary Solvent Mixtures of 2,2,4-Trimethylpentane + 2-Propanone + Alcohols at 298.15 K
  410. Naphthalene Solubility in Binary Solvent Mixtures of 2,2,4-Trimethylpentane + Alcohols at 298.15 K
  411. Solubility Prediction of Paracetamol in Water–Ethanol–Propylene Glycol Mixtures at 25 and 30 °C Using Practical Approaches
  412. Analysis of Oseltamivir in Tamiflu Capsules Using Micellar Electrokinetic Chromatography
  413. Headspace SPME–GC Method for Acetone Analysis and its Biomedical Application
  414. Electrocatalytic oxidation of hydrazine at overoxidized polypyrrole film modified glassy carbon electrode
  415. Solubility prediction in non-aqueous binary solvents using a combination of Jouyban-Acree and Abraham models
  416. Solubility prediction of anthracene in nonaqueous solvent mixtures using a combination of Jouyban-Acree and Abraham models
  417. Voltammetric behavior and determination of isoniazid in pharmaceuticals by using overoxidized polypyrrole glassy carbon modified electrode
  418. Theoretical and empirical approaches to express the mobility of small ions in capillary electrophoresis
  419. Predicting Solubility of Anthracene in Non-aqueous Solvent Mixtures Using a Combination of Jouyban-Acree and Abraham Models
  420. Solubility Prediction of Drugs in Water-Polyethylene Glycol 400 Mixtures Using Jouyban-Acree Model
  421. Solubility Prediction of Paracetamol in Binary and Ternary Solvent Mixtures Using Jouyban-Acree Model
  422. A simple spectrophotometric method for determination of sodium diclofenac in pharmaceutical formulations
  423. Genetic Algorithm Based Potential Selection in Simultaneous Voltammetric Determination of Isoniazid and Hydrazine by Using Partial Least Squares (PLS) and Artificial Neural Networks (ANNs)
  424. Modeling acid dissociation constant of analytes in binary solvents at various temperatures using Jouyban–Acree model
  425. Modeling the electrophoretic mobility of beta-blockers in capillary electrophoresis using artificial neural networks
  426. A Unified Cosolvency Model for Calculating Solute Solubility in Mixed Solvents
  427. Calculation of the Viscosity of Binary Liquids at Various Temperatures Using Jouyban-Acree Model
  428. Modeling the Entrainer Effects on Solubility of Solutes in Supercritical Carbon Dioxide
  429. Solubility prediction of anthracene in binary and ternary solvents by artificial neural networks (ANNs)
  430. Modeling drug solubility in water–cosolvent mixtures using an artificial neural network
  431. A simple relationship between dielectric constant of mixed solvents with solvent composition and temperature
  432. Surface Tension Calculation of Mixed Solvents with Respect to Solvent Composition and Temperature by Using Jouyban-Acree Model
  433. Electrophoretic behavior of alprenolol in mixed solvent electrolyte systems
  434. A quantitative structure property relationship study of electrophoretic mobility of analytes in capillary zone electrophoresis
  435. Calculation of electrophoretic mobility in ternary solvent electrolyte systems
  436. Comments concerning “solubility of anthracene in two binary solvents containing toluene”
  437. Comparison of different algorithms to calculate electrophoretic mobility of analytes as a function of binary solvent composition
  438. Mathematical representation of electrophoretic mobility of basic drugs in ternary solvent buffers in capillary zone electrophoresis
  439. Predicting electrophoretic mobility of beta-blockers in a water-methanol based electrolyte system
  440. Mathematical representation of apparent dissociation constants in aqueous–organic solvent mixtures
  441. Mathematical representation of solute solubility in supercritical carbon dioxide using empirical expressions
  442. Calculation of electrophoretic mobility in mixed solvent buffers in capillary zone electrophoresis using a mixture response surface method
  443. A model to represent solvent effects on the chemical stability of solutes in mixed solvent systems
  444. Solubility Prediction in Supercritical CO2 Using Minimum Number of Experiments
  445. A Cosolvency Model to Predict Solubility of Drugs at Several Temperatures from a Limited Number of Solubility Measurements.
  446. Solubility Prediction of Anthracene in Mixed Solvents Using a Minimum Number of Experimental Data.
  447. Calculation of the electrophoretic mobility of amines in methanol–aqueous electrolyte systems
  448. Solubility prediction of salmeterol xinafoate in water–dioxane mixtures
  449. Solubility Prediction for Furosemide in Water-Cosolvent Mixtures Using the Minimum Number of Experiments
  450. Mathematical representation of electrophoretic mobility in mixed aqueous‐methanolic buffers in capillary zone electrophoresis
  451. Calculation of electrophoretic mobilities in water–organic modifier mixtures in capillary electrophoresis
  452. Prediction of Drug Solubility in Ternary Solvent Mixture
  453. Comment on “Margules Equations Applied to PAH Solubilities in Alcohol−Water Mixtures”
  454. Correspondence
  455. Comparison of various cosolvency models for calculating solute solubility in water–cosolvent mixtures
  456. Comparison of models for describing multiple peaks in solubility profiles
  457. Solubility correlation of structurally related drugs in binary solvent mixtures
  458. Erratum
  459. A novel method for improvement of predictability of the CNIBS/R-K equation
  460. A general model from theoretical cosolvency models
  461. Models for calculating solubility in binary solvent systems
  462. Comparison of double log-log, mixture response-surface and combined NIBS/Redlich-Kister solubility models